Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stellbrink

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Archives of Pathology & Laboratory Medicine|August 1, 1997
Epstein-Barr virus--Associated hemophagocytic syndrome. A cause of fever of unknown origin in human immunodeficiency virus infectionH Albrecht, H Schäfer, H J Stellbrink, et al.
The Journal of Infectious Diseases|October 9, 1999
Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy--a longitudinal studyC Eggers, H J Stellbrink, T Buhk, et al.
Klinische Wochenschrift|October 31, 1991
Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatmentS Fenske, H J Stellbrink, H Albrecht, et al.
AIDS (London, England)|June 5, 1999
Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study GroupD A Revicki, G Moyle, H J Stellbrink, et al.
HIV Medicine|February 5, 2020
The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single-tablet regimen in the expanding spectrum of fixed-dose combination therapy for HIVH-J Stellbrink, A Lazzarin, I Woolley, et al.
Deutsche Medizinische Wochenschrift (1946)|February 27, 1987
[Long-term results in 172 highly malignant non-Hodgkin's lymphomas with special reference to older patients]R Kuse, A Calavrezos, H J Stellbrink, et al.
AIDS (London, England)|June 1, 1995
Treatment of disseminated Mycobacterium genavense infectionH Albrecht, S Rüsch-Gerdes, H J Stellbrink, et al.
AIDS (London, England)|October 9, 1998
Highly active antiretroviral therapy leads to a significant but delayed increase of CD45RA+ T-helper cellsO Degen, H J Stellbrink, J Lauer, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 17, 2004
Severe myelitis following infection with Campylobacter enteritisJ Aberle, J Kluwe, F Pawlas, et al.
Pneumologie (Stuttgart, Germany)|November 1, 1993
[Double infection of the lung with Pneumocystis carinii and Cryptococcus neoformans in an AIDS patient]H Albrecht, H J Stellbrink, S Fenske, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Archives of Pathology & Laboratory Medicine|August 1, 1997
Epstein-Barr virus--Associated hemophagocytic syndrome. A cause of fever of unknown origin in human immunodeficiency virus infectionH Albrecht, H Schäfer, H J Stellbrink, et al.
The Journal of Infectious Diseases|October 9, 1999
Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy--a longitudinal studyC Eggers, H J Stellbrink, T Buhk, et al.
Klinische Wochenschrift|October 31, 1991
Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatmentS Fenske, H J Stellbrink, H Albrecht, et al.
AIDS (London, England)|June 5, 1999
Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study GroupD A Revicki, G Moyle, H J Stellbrink, et al.
HIV Medicine|February 5, 2020
The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single-tablet regimen in the expanding spectrum of fixed-dose combination therapy for HIVH-J Stellbrink, A Lazzarin, I Woolley, et al.
Deutsche Medizinische Wochenschrift (1946)|February 27, 1987
[Long-term results in 172 highly malignant non-Hodgkin's lymphomas with special reference to older patients]R Kuse, A Calavrezos, H J Stellbrink, et al.
AIDS (London, England)|June 1, 1995
Treatment of disseminated Mycobacterium genavense infectionH Albrecht, S Rüsch-Gerdes, H J Stellbrink, et al.
AIDS (London, England)|October 9, 1998
Highly active antiretroviral therapy leads to a significant but delayed increase of CD45RA+ T-helper cellsO Degen, H J Stellbrink, J Lauer, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 17, 2004
Severe myelitis following infection with Campylobacter enteritisJ Aberle, J Kluwe, F Pawlas, et al.
Pneumologie (Stuttgart, Germany)|November 1, 1993
[Double infection of the lung with Pneumocystis carinii and Cryptococcus neoformans in an AIDS patient]H Albrecht, H J Stellbrink, S Fenske, et al.
Pageof 10